4baseCare

4baseCare

Private
Bangalore, KarnatakaHealthcare & Life Scienceshttps://www.4basecare.com

Last Round

Series B

Jun 11, 2026

Total Funding Raised

$21.3M

Momentum Score

50 /100

Company Overview

4baseCare is a genomics and digital health company that develops innovative technologies aimed at revolutionizing precision oncology in Asia by creating a comprehensive, patient-focused ecosystem that supports pharmaceutical companies in delivering personalized cancer treatments for improved clinical outcomes.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical AI, Patient Engagement, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision oncologygenomic profilingNGS testingcancer genomicsliquid biopsyNext-Generation SequencingNGStumor sequencingtargeted therapymolecular diagnosticspersonalized oncologypopulation-specific gene panelcancer diagnosticshereditary cancer testingCAP accreditationdigital health platformcancer patient app

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

4baseCare Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

4baseCare Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BJun 11, 2026
Series AAug 12, 2024
Early FundingMar 11, 2021

Key People

Founding team and executive leadership

Kshitij Rishi

Co-founder And COO

Founding Team

Hitesh Goswami

Co-Founder CEO

Founding Team

4baseCare Investors

Notable investors and investment history

InvestorRounds
GrowX VenturesEarly Funding
Season Two VenturesEarly Funding
Mount Judi VenturesEarly Funding
Yali CapitalSeries B, Series A
growX venturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 11, 2026

    $13M round led by growX ventures and Infosys.

  • Feb 19, 2026

    Collaborated with Owkin to advance inclusive cancer research.

4baseCare Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

4baseCare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 4baseCare's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore, Karnataka
Employee Range291
Year Founded2018
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.